Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease.
about
Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's DiseaseMitochondrial dysfunction: different routes to Alzheimer's disease therapyStructural evolution and membrane interactions of Alzheimer's amyloid-beta peptide oligomers: new knowledge from single-molecule fluorescence studiesThe delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiologyDirect observation of single amyloid-β(1-40) oligomers on live cells: binding and growth at physiological concentrationsGender-Specific Hippocampal Dysrhythmia and Aberrant Hippocampal and Cortical Excitability in the APPswePS1dE9 Model of Alzheimer's DiseaseOxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.Effects of 4-hydroxy-nonenal and Amyloid-beta on expression and activity of endothelin converting enzyme and insulin degrading enzyme in SH-SY5Y cells.Xanthoceraside ameliorates mitochondrial dysfunction contributing to the improvement of learning and memory impairment in mice with intracerebroventricular injection of aβ1-42.A prochelator activated by beta-secretase inhibits Abeta aggregation and suppresses copper-induced reactive oxygen species formation.Despite its role in assembly, methionine 35 is not necessary for amyloid beta-protein toxicityA peptide that binds specifically to the β-amyloid of Alzheimer's disease: selection and assessment of anti-β-amyloid neurotoxic effects.Design, synthesis, and biological evaluation of novel fluorinated ethanolamines.Catalytic antioxidants and neurodegenerationSomatostatin modulates insulin-degrading-enzyme metabolism: implications for the regulation of microglia activity in ADToll-like receptors in Alzheimer's diseaseN-acetylcysteine prevents 4-hydroxynonenal- and amyloid-beta-induced modification and inactivation of neprilysin in SH-SY5Y cellsAn overview on the correlation of neurological disorders with cardiovascular disease.Amyloid beta-protein assembly and Alzheimer disease.Substantial contribution of the two imidazole rings of the His13-His14 dyad to Cu(II) binding in amyloid-β(1-16) at physiological pH and its significance.Neuronal and vascular oxidative stress in Alzheimer's disease.Binding of β-amyloid (1-42) peptide to negatively charged phospholipid membranes in the liquid-ordered state: modeling and experimental studiesKetone body therapy: from the ketogenic diet to the oral administration of ketone ester.Motor Cortex Theta and Gamma Architecture in Young Adult APPswePS1dE9 Alzheimer Mice.Monitoring β-secretase activity in living cells with a membrane-anchored FRET probe.Advances in the pathogenesis of Alzheimer's disease: a re-evaluation of amyloid cascade hypothesis.Single-molecule imaging reveals aβ42:aβ40 ratio-dependent oligomer growth on neuronal processesThe structure of the amyloid-beta peptide high-affinity copper II binding site in Alzheimer disease.Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation.Reassessing the amyloid cascade hypothesis of Alzheimer's diseaseEffects of HNE-modification induced by Abeta on neprilysin expression and activity in SH-SY5Y cells.Pharmacotherapeutic targets in Alzheimer's diseaseRole of copper and cholesterol association in the neurodegenerative process.Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease.Precise assembly and regulation of 26S proteasome and correlation between proteasome dysfunction and neurodegenerative diseases.The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease.The use of mass spectrometry to study amyloid-β peptides.Protein aggregate spreading in neurodegenerative diseases: problems and perspectivesTargeting Glycogen Synthase Kinase-3β for Therapeutic Benefit against Oxidative Stress in Alzheimer's Disease: Involvement of the Nrf2-ARE Pathway.Glycogen synthase kinase-3β: a mediator of inflammation in Alzheimer's disease?
P2860
Q26801929-1C2178BB-15EE-45F3-9F40-927C655997D6Q27009475-62CB4D55-803C-4945-98B9-91E7B770A64FQ27010584-CE90C1AA-1AC3-4A2C-9EEF-C14083704929Q27015793-2EE9F099-4B21-4249-B49C-0B8C1041EFDDQ28476715-8F77EF5D-4752-443A-904C-AEEAB1D90424Q30827278-3EF7B07D-1934-481D-A4C1-F2EEC80D284BQ33506441-1F290AAD-C594-4BE3-98DB-E9052A60C53EQ33642530-952576E0-110A-4EDA-A5DE-E9861B42FCC6Q33757597-2EC91778-C35C-48A6-B31E-1C132181BCC5Q33815126-B97F5FDC-A999-4399-A09B-1FB6810ECFB2Q34012473-22D27031-8226-4F6A-B2E8-5DCE74593CF1Q34079353-1635D0B8-3356-4778-BD12-9328F1F75A61Q34082529-0D3E702B-8EEB-432C-8F5C-4B87069F37D8Q34104938-01DF1A56-44B8-4C3F-B7F9-114C2820A5FEQ34235168-0B82C2B8-49D6-4267-8C92-CBCEE3F67397Q34548586-2E93905C-AD0C-4F41-B678-24F75964802AQ34581928-1F042366-4426-4793-BFAB-5310ED4AA437Q34800195-064F75C6-B019-441C-8ADD-D4A1CA227FC1Q34849544-C9B7423E-D707-4E04-980C-0CFEEE833168Q35162996-FEB6AE0E-6BEC-4E0D-A7AB-C38A79035491Q35687039-F1440FFC-18B8-41C1-88B8-28A30BA79F59Q36150783-562B84FB-9F07-46D1-B309-68D65BF2A090Q36197639-62D71CAA-F6E1-4FD1-883F-626E5FD39340Q36245638-EB7694A4-94DE-49BC-8F6E-232B723ACF7DQ36391328-5BB8FB1A-F2E8-4C69-B489-334BFB458668Q36478423-B30FFF10-509A-4432-9567-C8F9AA70C848Q36621979-B1CC759E-EF2F-414A-8657-242DB6ADE847Q36899891-E87055F8-FB72-4DA1-9167-3E800B7C1321Q37061979-90491ECF-898E-4A71-A7C2-AEB5BD128711Q37187966-2A8E1C6D-6F67-4F84-BC0F-0F889E2B8654Q37219722-DAAB0A3B-0C4E-4DBC-A3E8-18DFD809A48BQ37295067-550D2EBC-4552-40C7-98EB-52282889E6D8Q37316130-280A80D0-C575-43B6-B878-F5658D23A7E0Q37364086-BCE41E54-5397-4D4D-B902-24864DC39E9DQ37581070-607428A9-176D-46CF-AA87-9C827BA867E8Q37696521-295D81EB-4578-4F8E-8E15-FDFD5CED4B20Q37866222-64D3F29D-2282-4651-B4C1-6413B0FF2F83Q37882078-0571E098-6CFB-450A-BE7E-6CCA021D4FD8Q37883102-B77120CA-269E-43F7-BDF9-00AC9FBBC775Q37883104-F5978FE2-E29A-437F-AA0B-874603722F91
P2860
Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease.
@en
type
label
Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease.
@en
prefLabel
Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease.
@en
P50
P1476
Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease.
@en
P2093
James Camakaris
P304
P356
10.1016/J.BIOCEL.2007.07.013
P577
2007-08-01T00:00:00Z